OBI Presents Next-Generation Bispecific Dual-Payload ADC Development at World ADC London 2026

Dr. Ya-Chi Chen, Chief Scientific Officer of OBI Pharma (4174.TWO), was invited as a featured speaker in the “Top Novel ADC Development” session at World ADC London 2026, which was held in the United Kingdom from February 23 to 26. Her presentation was one of four talks selected for the session. Dr. Chen also participated in a panel discussion titled “What’s the New Path to the Next Generation of ADCs”.